UBS AM’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-7,450
Closed -$142K 2855
2018
Q3
$142K Hold
7,450
﹤0.01% 2499
2018
Q2
$422K Hold
7,450
﹤0.01% 2169
2018
Q1
$315K Buy
7,450
+3,960
+113% +$170K ﹤0.01% 2184
2017
Q4
$187K Hold
3,490
﹤0.01% 2334
2017
Q3
$156K Hold
3,490
﹤0.01% 2312
2017
Q2
$170K Buy
3,490
+1,960
+128% +$115K ﹤0.01% 2273
2017
Q1
$111K Hold
1,530
﹤0.01% 2289
2016
Q4
$88K Sell
1,530
-2,320
-60% -$213K ﹤0.01% 2265
2016
Q3
$493K Hold
3,850
﹤0.01% 1988
2016
Q2
$480K Buy
3,850
+520
+16% +$59.8K ﹤0.01% 1972
2016
Q1
$278K Sell
3,330
-1,383
-29% -$114K ﹤0.01% 2254
2015
Q4
$466K Sell
4,713
-59,127
-93% -$6.34M ﹤0.01% 2092
2015
Q3
$7.83M Buy
63,840
+7,018
+12% +$953K 0.01% 922
2015
Q2
$8.72M Buy
56,822
+54,372
+2,219% +$8.97M 0.01% 928
2015
Q1
$418K Buy
2,450
+140
+6% +$21.2K ﹤0.01% 2079
2014
Q4
$353K Buy
2,310
+330
+17% +$41.2K ﹤0.01% 2124
2014
Q3
$210K Hold
1,980
﹤0.01% 2350
2014
Q2
$301K Hold
1,980
﹤0.01% 2184
2014
Q1
$255K Buy
1,980
+200
+11% +$31.1K ﹤0.01% 2283
2013
Q4
$310K Buy
1,780
+140
+9% +$24.1K ﹤0.01% 2107
2013
Q3
$265K Hold
1,640
﹤0.01% 2161
2013
Q2
$218K Buy
+1,640
New +$232K ﹤0.01% 2229

Other funds holding ELGX

UBS AM's ELGX Position: Q4 2018 in Review

UBS AM sold out of Endologix Inc (ELGX) in Q4 2018, closing a stake of 7,450 shares — an estimated $142K sold.

UBS AM first reported a position in ELGX in Q2 2013 and held it in 22 quarters. The position peaked at $8.72M in Q2 2015. 99 funds tracked by Wall St. Rank hold ELGX as of Q4 2018.

  • UBS AM reported no remaining Endologix Inc position as of Q4 2018 after selling out during the quarter.
  • UBS AM sold 7,450 Endologix Inc shares in Q4 2018, an estimated $142K.
  • UBS AM first reported a position in Endologix Inc in Q2 2013 and held it in 22 quarters.
  • UBS AM's Endologix Inc position peaked at $8.72M in Q2 2015.
  • 99 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2018.

Based on UBS AM's 13F filing for Q4 2018, filed 13 Feb 2019.